ESC 365 - Discussion - Managing diabetes & CVD: is epigenetics a new way forward?

ESC Premium Access

Discussion - Managing diabetes & CVD: is epigenetics a new way forward?

Session: Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)

Topic: Drug therapy

Speaker: Professor R. Kausik

Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Resverlogix

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Ray Kausik

3 presentations

0 follower

4 more presentations in this session

Introduction - Managing diabetes & CVD: is epigenetics a new way forward?

Speaker: Professor L. Badimon (Barcelona, ES)

Managing high risk diabetes patient with cardiovascular disease: what works, and what else can we do?

Speaker: Professor R. Kausik

Promise of epigenetic modulation as a target in atherosclerotic patients.

Speaker: Professor E. Stroes (Amsterdam, NL)

Insights from the first trials in epigenetics in human: what is the way forward?

Speaker: Professor S. Nicholls (Melbourne, AU)

Access the full session

Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)

Speakers: Professor R. Kausik, Professor L. Badimon, Professor R. Kausik, Professor E. Stroes, Professor S. Nicholls

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources